| McKeage K, Scott LJ SLI-381 (Adderall XR). [Journal Article] CNS Drugs 2003; 17(9):669-75; discussion 676-7. Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Tulloch SJ, Zhang Y, McLean A, et al. SLI381 (Adderall XR), a two-component, extended-release formulation of mixed amphetamine salts: bioavailability of three test formulations and comparison of fasted, fed, and sprinkled administration. [Clinical Trial, Journal Article, Randomized Controlled Trial] Pharmacotherapy 2002 Nov; 22(11):1405-15. Abstract | Full Citation | Find Related Articles | | Biederman J, Lopez FA, Boellner SW, et al. A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention-deficit/hyperactivity disorder. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial] Pediatrics 2002 Aug; 110(2 Pt 1):258-66. Abstract | Full Citation | Publisher Full Text | Find Related Articles | |
|
| | Advertise on this site.
|